Abstract
Pseuderanthemum palatiferum (Nees) Radlk. has been used extensively as a medicinal plant for the treatment of diabetes mellitus in various parts of Southeast Asia. However, the mechanism of its anti-diabetic action has not been fully characterized yet. The objectives of this study were to investigate the in vitro effects of P. palatiferum leaf ethanolic extract (PPE extract) on adipocyte lipolysis, α-amylase enzyme activity and antioxidant activity. The PPE extract at every concentration tested (10, 25, 50, 100, 250, 500 µg/ml) caused a significant inhibition on basal lipolysis in adipocytes of the high fat diet-fed rats. The PPE extract also produced a concentration-dependent anti-lipolytic action against isoprenaline (0.1 µM)-induced lipolysis in the normal pellet diet-fed rat derived adipocytes. Inhibition of α-amylase was detected using the 3,5-dinitrosalicylic acid assay, the PPE extract having an IC50 of 4.99 mg/ml. An antioxidant activity, as evaluated by the DPPH assay (IC50), was 58.13 µg/ml. In the ferric reducing power assay, the extract exerted antioxidant activity with a vitamin C equivalent antioxidant capacity (VCEAC) and a trolox equivalent antioxidant capacity (TEAC) of 2.33 and 2.04 g/100 g extract, respectively. The anti-lipolytic, α-amylase inhibitory and antioxidant activities of PPE extract detected here help justify the traditional use of this plant in the treatment of diabetes mellitus. Key words: Pseuderanthemum palatiferum, diabetes mellitus, adipocyte lipolysis, α-amylase, 2,2-diphenyl-1-picrylhydrazyl (DPPH) assay, ferric reducing power assay.
Highlights
IntroductionDiabetes mellitus (DM) is a chronic metabolic disorder caused by impairment in insulin secretion and/or insulin
The glycerol concentration released from adipocytes of the normal pellet diet (NPD)-fed rats was 86.17 ± 2.10 μg ml-1/ml packed cell volume (PCV)/h (n = 4)
2.04 g/100 g extract, respectively. Both basal lipolysis and isoprenaline (0.1 μM)-stimulated lipolysis were investigated in adipocytes derived from the NPD- or high fat diet (HFD)-fed rats
Summary
Diabetes mellitus (DM) is a chronic metabolic disorder caused by impairment in insulin secretion and/or insulin. The incidence of DM, especially type 2 DM has increased substantially in modern society in which people live with a sedentary lifestyle. Treatment of type 2 DM includes both drug therapy and lifestyle modifications (ADA, 2014). Several groups of anti-diabetic agents with various mechanisms of action have been developed, certain treatment problems, including unresponsiveness and adverse drug reactions, still arise regularly. The high cost of some novel antidiabetic agents is another main obstacle in diabetic treatment, especially in developing countries. Other treatment options, medicinal plants, have been used widely as alternative anti-diabetic therapies
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
